Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Jag1
REST API REST API
Rattus norvegicus
Jag1 is differentially expressed in 64 experiments: 51 organism parts: hippocampus, frontal cortex, ... (49 more);, 8 disease states: normal, BDL 7 days, ... (6 more);, 10 cell types 7 compound treatments 2 clinical treatments and 16 other conditions.
Orthologs Jag1 (Mus musculus)   ENSCING00000004617 (Ciona intestinalis)   jag1b (Danio rerio)   JAG1 (Homo sapiens)   jag1a (Danio rerio)   Q90819_CHICK (Gallus gallus)   Ser (Drosophila melanogaster)   jag1 (Xenopus laevis)   (Compare orthologs)
InterPro Term EGF-like_reg_CS, Notch_ligand_N, VWF_C, EGF-type_Asp/Asn_hydroxyl_site, EGF_extracell, Prot_inh_PMP, EGF, DSL, VWC_out, EGF_3, EGF-like, EGF_Ca-bd_2, EGF_Ca-bd, EGF_Ca-bd_CS
Gene Ontology Term plasma membrane, protein binding, morphogenesis of an epithelial sheet, regulation of cell proliferation, cell fate determination, membrane, positive regulation of Notch signaling pathway, peptidase inhibitor activity, cell differentiation, cell communication, multicellular organismal development, Notch binding, Notch signaling pathway, apical part of cell, integral to membrane, negative regulation of cell differentiation, calcium ion binding, organ morphogenesis, inner ear development, positive regulation of myeloid cell differentiation, negative regulation of neuron differentiation, response to muramyl dipeptide, negative regulation of fat cell differentiation, auditory receptor cell differentiation, distal tubule development, neuronal stem cell maintenance, loop of Henle development, negative regulation of stem cell differentiation
UniProt Accession Q63722
Search EB-eye ENSRNOG00000007443
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15184, E-GEOD-3309, E-GEOD-19830, E-GEOD-2354, E-GEOD-20388, ... (17 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell type

studied in E-GEOD-5940, E-MEXP-31, E-GEOD-830, E-TABM-130, E-GEOD-2032 ... (5 experiments)

Factor Value U/D Experiments
tubular somatic cell
1
E-GEOD-830
spermatogonia
1
E-MEXP-31
1
E-TABM-130
oligodendrocyte
1
E-GEOD-5940
oligodendrocyte progenitor cell
1
E-GEOD-5940
fibroblast
1
E-GEOD-2032
4 more value(s).


Disease state

studied in E-GEOD-1872, E-MEXP-1025, E-GEOD-594, E-MTAB-104, E-MEXP-2583 ... (5 experiments)

Factor Value U/D Experiments
Sham
1
E-MEXP-2583
bone fracture
1
E-GEOD-594
normal
2
1
E-GEOD-594, E-GEOD-1872, E-MTAB-104
bladder carcinoma
1
E-MTAB-104
experimental autoimmune encephalomyelitis (acute)
1
E-MEXP-1025
experimental autoimmune encephalomyelitis (recovery)
1
E-MEXP-1025
2 more value(s).


Compound treatment

studied in E-GEOD-424, E-GEOD-2303, E-GEOD-6119, E-GEOD-1978

Factor Value U/D Experiments
butyrate
1
E-GEOD-424
interleukin 1 beta
1
1
E-GEOD-6119
diethylhexylphthalate
1
E-GEOD-2303
interleukin 1 beta and glucosamine
1
E-GEOD-6119
valproic acid
1
E-GEOD-2303
control
1
1
8
E-GEOD-6119, E-GEOD-1978
1 more value(s).


Clinical treatment

studied in E-GEOD-738, E-MTAB-104

Factor Value U/D Experiments
implanted tumor
1
E-MTAB-104
aortic banding - sham
1
E-GEOD-738


Cohort

studied in E-GEOD-20388

Factor Value U/D Experiments
Cohort 1
1
E-GEOD-20388
Cohort 2
1
E-GEOD-20388


compound_treatment_design
studied in E-TABM-12

Day
studied in E-GEOD-20659

Developmental stage
studied in E-MEXP-570, E-GEOD-903

Environmental stress
studied in E-GEOD-2875

Genetic modification
studied in E-GEOD-6428

Genotype
studied in E-GEOD-20214

Growth condition
studied in E-GEOD-7501

Injury
studied in E-GEOD-1371

Material type
studied in E-GEOD-4192, E-MEXP-2527

protocol
studied in E-GEOD-20895

Protocol type
studied in E-GEOD-1616, E-MEXP-1565

Replicate
studied in E-GEOD-4192

Sampling time point
studied in E-MEXP-1565

Strain or line
studied in E-MTAB-322, E-TABM-457, E-TABM-418, E-GEOD-599, E-TABM-45 ... (5 experiments)

Treatment
studied in E-GEOD-15184, E-GEOD-19909, E-GEOD-22531

Processing time: 0.241 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM